Morgan Stanley Maintains Equal-Weight on Innovid, Lowers Price Target to $2.2

Morgan Stanley analyst Brian Nowak maintains Innovid (NYSE:CTV) with a Equal-Weight and lowers the price target from $2.4 to $2.2.

Morgan Stanley analyst Brian Nowak maintains Innovid (NYSE:CTV) with a Equal-Weight and lowers the price target from $2.4 to $2.2.

Total
0
Shares
Related Posts